Arabic Arabic English English French French German German
dark

Use of certain prescription meds linked to COVID-19 mortality

(HealthDay)—A potential COVID-19 survival benefit is suggested in association with initiation or continuation of an angiotensin-converting enzyme inhibitor (ACE-I), an angiotensin receptor blocker (ARB), or metformin for hospitalized patients, according to a study published in the December issue of The BMJ. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Cognitive decline not always a sign of Alzheimer’s disease

Next Post

Children’s behavior at home worse during remote learning

Related Posts
Total
0
Share